[EN] DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS<br/>[FR] INHIBITEURS DE DIACYLGLYCÉROL ACYLTRANSFÉRASE 2
申请人:PFIZER
公开号:WO2018033832A1
公开(公告)日:2018-02-22
Compounds of Formula (I) that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
本文描述了抑制二酰甘油酰基转移酶 2(DGAT2)活性的式 I 化合物及其在治疗动物相关疾病中的用途。
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS
申请人:Pfizer Inc.
公开号:EP3500564A1
公开(公告)日:2019-06-26
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS
申请人:Pfizer Inc.
公开号:US20180051012A1
公开(公告)日:2018-02-22
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
KROWICKI K., ROCZ. CHEM. <ROCH-AC>, 1975, (1976), 49, NO 12, 2089-2094